Tuesday, April 28, 2026, 12:00 PM–1:00 PM ET
Discover how next-day comprehensive genomic profiling (CGP) is possible with the Oncomine Comprehensive Assay Plus on the Genexus System—delivering both speed and accuracy.
Webinar presenters Jane Bayani, MHSc, PhD, Assistant Professor and Co-Director, Diagnostic Development, Ontario Institute for Cancer Research, Canada, and Nicola Normanno, MD, Scientific Director, IRCCS Romagnolo Institute for the Study of Tumors, Italy, and Morten Grauslund, PhD, Molecular Biologist, Department of Pathology, Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher Scientific. For Research Use Only. Not for use in diagnostic applications.
Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.
Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
A review paper released by cancer diagnostics firm Dako aims to provide prostate pathologists a comprehensive reference on the use of various prostate markers, as well as their limitations. Download the paper.
Keith J. Kaplan, MD, discusses his lab’s experience with the Sakura VisionTek Digital Microscope. At the Digital Pathology Blog, Dr. Kaplan calls the system “a must-see for real-time applications with point-to-point case sharing.” Read more.
In this HIStalk interview, Partners HealthCare pathology project director Lyman Garniss addresses the challenge laboratories face in managing genomic information, how EMR systems still fall short when compared with LIS, and the promise of biorepositories.
Viewics Inc., which makes software designed to help clinical and anatomic pathology laboratories with their dashboarding and data-mining needs, is offering a free demonstration on Thursday, Jan. 23. The demo aims to showcase how the company’s product can help track revenue and volume, analyze per-test costs and supply expenses, identify TAT outliers, and scrutinize workload, staffing, and QA/QC issues.Register.
Read how a patient risk approach to QC means planning your QC based on the type or method of the test and its impact on patient outcomes when a failure is detected.
Validating Whole Slide Imaging for Diagnostic Purposes in Pathology: This guideline, available in Archives of Pathology & Laboratory Medicine, marks a significant step in demonstrating the value of this emerging technology for diagnostic use.
Executives at Carmel, Ind.-based laboratory information system company Orchard Software share their views on how health care’s change from a volume-based to a value-based service model will affect the lab. This presentation points out specific ways that the laboratory can deliver for its facility and its customers in a value-based reimbursement world. Watch the video.
Digital Pathology Association Webinar, The use of digital pathology technology in research environment, features Robert W. Dunstan and Christopher D. Higgins.
GenMark offers on Tuesday, Sept. 17 for a free webinar on multiplex respiratory virus testing. As part of the webinar, Benjamin Pinsky, MD, PhD, Stanford University, will discuss the transition from traditional culture and direct antigen testing to molecular diagnostics. P.A.C.E. credit available. Register here.
AdvaMedDx’s free executive newsletter for August 2013 is now available. Covered in the newsletter is information about a diagnostics payment reform bill, FDA news on companion diagnostic tests, and views from the company’s director Andrew C. Fish. [Download here] * More CAP TODAY Recommends * *
